PolyPid
PolyPid Soars 3.4% on Pivotal FDA Endorsement for D-PLEX100 NDA
Jerusalem, Israel – December 3, 2025 – PolyPid Ltd. (NASDAQ: PYPD) witnessed a significant surge in its stock price today, gaining 3.4% following the announcement of supportive feedback from the U.S. Food and Drug Administration (FDA) regarding its pre-New Drug Application (NDA) meeting for D-PLEX100. This crucial regulatory milestone de-risks